Knoll Synthroid settlement
Executive Summary
Company agrees to provide $41.8 mil. to states for "consumer education, litigation, public protection or local consumer aid funds" as part of a settlement agreement with 37 state Attorneys General. The states initiated litigation relating to Knoll's blocking publication of the "Dong study" that found levothyroxine generics to be bioequivalent to Synthroid